Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 947M 823M 768M 705M 1.33B 90.26B 1.35B 9.06B 3.55B 45.01B 3.56B 3.48B 148B P/E 2026 *
-20.7x
P/E 2027 * -27.6x
Enterprise Value 960M 835M 779M 715M 1.35B 91.55B 1.37B 9.19B 3.6B 45.65B 3.61B 3.53B 151B EV / Sales 2026 *
4.56x
EV / Sales 2027 * 4.04x
Free-Float
41.44%
Yield 2026 *
-
Yield 2027 * -
1 day-2.28%
1 week-4.04%
Current month-2.28%
1 month+6.29%
3 months+72.12%
6 months+96.93%
Current year+97.54%
1 week 6.28
Extreme 6.28
6.94
1 month 5.67
Extreme 5.67
7.44
Current year 2.8
Extreme 2.8
7.44
1 year 1.99
Extreme 1.99
7.44
3 years 1.66
Extreme 1.665
11.7
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
6/8/26 Tax

Chief Executive Officer

-351,001 0.2380%
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-4.04%+189.19%-46.77% 947M
-3.17%-19.35%+89.72%+76.02% 3.61B
+2.39%+2.53%+123.72%+231.56% 3.68B
+9.47%+31.60%+291.57%+345.95% 2.48B
-0.42%+0.96%-27.65%-36.82% 2.16B
+6.02%-11.94%+61.01%-40.32% 1.93B
-0.74%-5.32%-8.09%+5.95% 850M
+1.46%+5.42%-37.98%-11.28% 519M
+2.80%-3.38%+2.52% - 464M
+4.98%+8.50%-3.00%-66.18% 167M
Average +2.05%+2.08%+68.10%+50.90% 1.68B
Weighted average by Cap. +1.88%+0.18%+101.92%+108.33%

Financials

2026 *2027 *
Net sales 210M 183M 171M 157M 296M 20.06B 301M 2.01B 789M 10B 790M 773M 32.99B 226M 196M 183M 168M 317M 21.53B 323M 2.16B 846M 10.74B 848M 830M 35.41B
Net income -39.2M -34.06M -31.8M -29.2M -55.05M -3.74B -56.01M -375M -147M -1.86B -147M -144M -6.15B -28.2M -24.51M -22.88M -21M -39.61M -2.69B -40.3M -270M -106M -1.34B -106M -104M -4.42B
Net Debt 13.46M 11.69M 10.92M 10.02M 18.9M 1.28B 19.23M 129M 50.42M 640M 50.54M 49.43M 2.11B -33.46M -29.08M -27.15M -24.93M -47M -3.19B -47.82M -320M -125M -1.59B -126M -123M -5.25B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-08-03 US$6.420 -2.28% 2,047,047
26-07-31 US$6.570 -2.67% 1,087,353
26-07-30 US$6.750 +2.43% 1,251,381
26-07-29 US$6.590 -3.94% 1,931,709
26-07-28 US$6.860 +2.54% 2,412,772
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
6.420USD
Average target price
5.900USD
Spread / Average Target
-8.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock